Perrigo Names Head Of Regulatory Review - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Perrigo Names Head Of Regulatory Review

Perrigo has appointed Keith Webber as head of regulatory review, effective Oct. 21, 2013 with responsibility for advancing the approval of all of Perrigo's consumer healthcare and prescription pharmaceutical regulatory applications pending with FDA, providing guidance on scientific and regulatory strategy for pipeline products, and advancing the quality of new regulatory applications.

Webber previously was Acting Director of the Office of the FDA's Pharmaceutical Science in the Center for Drug Evaluation and Research.

Source: Perrigo


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here